entertainment -WSS

entertainment

author：hotspot 2025-10-01 11:45:15 - browse：39

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Tome Biosciences co

WSS

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Bernie Sanders gets little from pharma CEOs on drug prices

Home health providers sue Medicare over payment cuts

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

hotspot

entertainment

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Judge agrees to delay next hearing in Trump classified documents case

Drug repurposing or repositioning? The language matters

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Apple is now the first public company to be valued at $3 trillion

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Cancer drug shortages should be causing more outrage

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

As demand for Covid shots wanes, Moderna seeks its next success

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Wikipedia

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Congress must protect the remaining independent doctors

Biden declares emergency in flood

Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

hotspot

entertainment

Wikipedia